V CompBrief BY VELARION

Independent Director · ARS Pharmaceuticals, Inc. (SPRY)

Chair, Nominating/Governance Committee

Peter Kolchinsky director compensation at ARS Pharmaceuticals: $430K

Fiscal year 2025 director compensation for Peter Kolchinsky at ARS Pharmaceuticals, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 29, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Peter Kolchinsky’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Peter Kolchinsky and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

ARS Pharmaceuticals Director Compensation Table · all 3 fiscal years held
In US dollars, as ARS Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$62,500—$367,959$0$430,459
FY2024$55,000—$232,932$0$287,932
FY2023$55,000—$198,800$0$253,800

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ARS Pharmaceuticals, Inc. DEF 14A filed April 29, 2026, accession 0001193125-26-191433, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ARS Pharmaceuticals, Inc. filed document, accession 0001193125-26-191433. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.

Get the ARS Pharmaceuticals Board Governance Report

$430,459 Peter Kolchinsky, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 29, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

ARS Pharmaceuticals pays directors a $50,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Nominating/Governance (Chair)

The rest of the ARS Pharmaceuticals board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Brenton L. SaundersIndependent Director$435,459
Laura ShawverIndependent Director$417,751
Michael KellyIndependent Director$435,459
Peter A ThompsonIndependent Director$422,959
Phillip SchneiderIndependent Director$440,459
Pratik ShahIndependent Director$689,209
Rajeev DadooIndependent Director$425,459

The full ARS Pharmaceuticals compensation record

free company brief
ARS Pharmaceuticals, Inc. (SPRY) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within ARS Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the ARS Pharmaceuticals proxy · each links to its own free brief

Order SPRY

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report